Vectura Group has made an appointment to support innovation, customer focus and growth as the company continues with its strategic development as an inhalation specialist in the pharmaceutical services space. 
 

Sharon Johnson has been named executive vice president for delivery management, a new position focused on helping the company to transform into a successful contract development and manufacturing organization (CDMO). In her new role, Ms. Johnson will build an end-to-end approach to ensuring successful customer acquisition and program management, as well as managing the regulatory affairs and medical affairs departments.
 
“Sharon has built an enviable reputation as an exceptional leader in the pharmaceutical services space and has a strong track record of transformational leadership, talent development and execution excellence,” said said Will Downie, chief executive officer, Vectura. “Our new structure will support growth and sharpen our focus on working with our clients to bring more inhalation medicines to market.”
 
Ms. Johnson has more than thirty years of experience in the pharmaceutical industry, and prior to joining Vectura has held a number of executive positions, most recently as senior vice president, global quality and regulatory affairs at Catalent. Earlier in her career, she held the position of vice president of quality for GE Healthcare’s medical diagnostic division.